These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 1724166)

  • 1. Clinical and biochemical effects of an oral leukotriene biosynthesis inhibitor (MK886) in psoriasis.
    de Jong EM; van Vlijmen IM; Scholte JC; Buntinx A; Friedman B; Tanaka W; van de Kerkhof PC
    Skin Pharmacol; 1991; 4(4):278-85. PubMed ID: 1724166
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topical steroid treatment reduces arachidonic acid and leukotriene B4 in lesional skin of psoriasis.
    Wong E; Barr RM; Cunningham FM; Mistry K; Woollard PM; Mallet AI; Greaves MW
    Br J Clin Pharmacol; 1986 Dec; 22(6):627-32. PubMed ID: 3032226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic and pharmacodynamic analysis of a novel leukotriene biosynthesis inhibitor, MK-0591, in healthy volunteers.
    Uematsu T; Kanamaru M; Kosuge K; Hara K; Uchiyama N; Takenaga N; Tanaka W; Friedman BS; Nakashima M
    Br J Clin Pharmacol; 1995 Jul; 40(1):59-66. PubMed ID: 8527269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blockade of leukotriene production by a single oral dose of MK-0591 in active ulcerative colitis.
    Hillingsø J; Kjeldsen J; Laursen LS; Lauritsen K; von Spreckelsen S; Depré M; Friedman BS; Malmström K; Shingo S; Bukhave K
    Clin Pharmacol Ther; 1995 Mar; 57(3):335-41. PubMed ID: 7697951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Skin levels of arachidonic acid-derived inflammatory mediators and histamine in atopic dermatitis and psoriasis.
    Ruzicka T; Simmet T; Peskar BA; Ring J
    J Invest Dermatol; 1986 Feb; 86(2):105-8. PubMed ID: 3018086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacologic and clinical effects of lonapalene (RS 43179), a 5-lipoxygenase inhibitor, in psoriasis.
    Black AK; Camp RD; Mallet AI; Cunningham FM; Hofbauer M; Greaves MW
    J Invest Dermatol; 1990 Jul; 95(1):50-4. PubMed ID: 2164070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduction of leukotriene B4-induced intraepidermal accumulation of polymorphonuclear leukocytes by methotrexate in psoriasis.
    Lammers AM; van de Kerkhof PC; Mier PD
    Br J Dermatol; 1987 May; 116(5):667-71. PubMed ID: 3036194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of MK-0591, a novel 5-lipoxygenase activating protein inhibitor, on leukotriene biosynthesis and allergen-induced airway responses in asthmatic subjects in vivo.
    Diamant Z; Timmers MC; van der Veen H; Friedman BS; De Smet M; Depré M; Hilliard D; Bel EH; Sterk PJ
    J Allergy Clin Immunol; 1995 Jan; 95(1 Pt 1):42-51. PubMed ID: 7822663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cutaneous responses to 12-hydroxy-5,8,10,14-eicosatetraenoic acid (12-HETE) and 5,12-dihydroxyeicosatetraenoic acid (leukotriene B4) in psoriasis and normal human skin.
    Dowd PM; Black AK; Woollard PW; Greaves MW
    Arch Dermatol Res; 1987; 279(7):427-34. PubMed ID: 2829751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topical R-85355, a potent and selective 5-lipoxygenase inhibitor, fails to improve psoriasis.
    van de Kerkhof PC; van Pelt H; Lucker GP; Steijlen PM; Heremans A
    Skin Pharmacol; 1996; 9(5):307-11. PubMed ID: 8990505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The inter-relation between inflammation and epidermal proliferation in normal skin following epicutaneous application of leukotriene-B4--an immunohistochemical study.
    de Jong EM; van Erp PE; van Vlijmen IM; van de Kerkhof PC
    Clin Exp Dermatol; 1992 Nov; 17(6):413-20. PubMed ID: 1336720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of 5-lipoxygenase products in the local accumulation of neutrophils in dermal inflammation in the rabbit.
    Marleau S; Fruteau de Laclos B; Sanchez AB; Poubelle PE; Borgeat P
    J Immunol; 1999 Sep; 163(6):3449-58. PubMed ID: 10477617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The chemokinetic response of psoriatic and normal polymorphonuclear leukocytes to arachidonic acid lipoxygenase products.
    Cunningham FM; Wong E; Woollard PM; Greaves MW
    Arch Dermatol Res; 1986; 278(4):270-3. PubMed ID: 3017241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epicutaneous application of leukotriene B4 induces patterns of tenascin and a heparan sulfate proteoglycan epitope that are typical for psoriatic lesions.
    Seyger MM; van Pelt JP; van den Born J; Latijnhouwers MA; de Jong EM
    Arch Dermatol Res; 1997 May; 289(6):331-6. PubMed ID: 9209678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipoxygenase products of arachidonic acid in human inflamed skin.
    Black AK; Barr RM; Wong E; Brain S; Greaves MW; Dickinson R; Shroot B; Hensby CN
    Br J Clin Pharmacol; 1985 Sep; 20(3):185-90. PubMed ID: 2994700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of leukotriene B4 in murine dermatitis models.
    Tsuji F; Miyake Y; Horiuchi M; Mita S
    Biochem Pharmacol; 1998 Feb; 55(3):297-304. PubMed ID: 9484795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of the in vivo biochemical efficacy of orally active leukotriene biosynthesis inhibitors.
    Tagari P; Brideau C; Chan C; Frenette R; Black C; Ford-Hutchinson A
    Agents Actions; 1993 Sep; 40(1-2):62-71. PubMed ID: 8147271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Eicosanoids in acute and chronic psoriatic lesions: leukotriene B4, but not 12-hydroxy-eicosatetraenoic acid, is present in biologically active amounts in acute guttate lesions.
    Fogh K; Herlin T; Kragballe K
    J Invest Dermatol; 1989 Jun; 92(6):837-41. PubMed ID: 2542417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increase in urinary leukotriene B4 glucuronide concentration in patients with aspirin-intolerant asthma after intravenous aspirin challenge.
    Mita H; Higashi N; Taniguchi M; Higashi A; Akiyama K
    Clin Exp Allergy; 2004 Aug; 34(8):1262-9. PubMed ID: 15298568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leukotriene B4 fails to induce penetration of polymorphonuclear leukocytes into psoriatic lesions.
    Lammers AM; van de Kerkhof PC
    Br J Dermatol; 1987 Nov; 117(5):541-4. PubMed ID: 2825753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.